CIPLA - Cipla | Wealthrox

Cipla

CIPLA · Pharma > Pharmaceuticals & Drugs · Chairman: Y K Hamied · MD: Umang Vohra · Listing date: Oct. 27, 1994 · Employees: 25672 · Mumbai · http://www.cipla.com

Stock Price vs Company Growth

0.3%

4.8%

3.9%

2.9%

20.1%

55.5%

20.8%

10y

14.2%

all

11.1%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,409 0.3%

1,313

1,519

Company Overview

Sales

25,350 Cr

Growth: 11.7%

Profit after Tax

3,708 Cr

Growth: 7.4%

Large Cap

1,13,794 Cr

P/E: 30.7x

Industry P/E: 35.5x

Fundamentals

Sales (Cr)	₹ 25,350
Growth	11.7%
EBITDA	24.3%
P/S	4.5x
Dividend	0.8%
P/E	30.7x
Book Value	₹ 329
PEG Ratio	2.6x
ROE	14.8%
P/B	4.3x

Shareholding Pattern

Institutions

Sbi Mutual Fund

3.45 %

Government Pension Fund Global

2.36 %

Life Insurance Corporation Of India

2.27 %

Icici Prudential Mutual Fund

1.68 %

Hdfc Mutual Fund

1.19 %

Promoters

Yusuf Khwaja Hamied

20.36 %

Sophie Ahmed

5.71 %

Mustafa Khwaja Hamied

4.29 %

Samina Hamied

2.22 %

Kamil Hamied

1.36 %

Others

Nps Trust

1.51 %

Icici Prudential Life Insurance Company Limited

0.93 %

Increase Decrease No change

Company Profile Detailed

The company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). The company has its wide network of manufacturing, trading and other incidental operations in India and International markets.ProductsGenerics and branded genericsSpecialtyConsumer healthAwards:2013:Ernst & Young awarded Dr. Y K Hamied with the Lifetime Achievement Award of the year 2013Dr.

Belongs to (38 Indices) view more

Investors (230)

m.k.hami...

kaustubh...

first.st...

Followers (44)

anusha.r...

deepak

abdul.ha...